ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy

August 1, 2014

GP Amendment To Waxman Bill Would Leave Dollar Levels The Same But would Drop Centers Line Item

August 5, 1983

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

Eight applications Received For NSABP chairman

September 9, 1994

The View Forom The White House On Research Funding

August 16, 1991

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979